The US company Moderna claims to develop a vaccine on the coronavirus. This was tested on Monday at the Washington Health Research Institute. The first trial included 45 healthy youth. These people are not infected with the coronavirus but have been included to detect the side effects of the vaccine. This news is varified by NY Times.
Highlights Of Coronavirus Vaccine
- The maker of this vaccine is the American pharma company Moderna. This is being trialed in collaboration with the National Institutes of Health, which is funding it. It will take 18 months to prepare even if the trial is successful.
- This vaccine is based on genetic engineering. When they give the injection, the body cells cut the virus into small pieces. With the help of these small pieces, the immune system of the body begins to identify the virus.
- The drug present in the injection affects the RNA which orders the immune system to capture its target or virus.
- According to scientific theory, when artificial RNA enters the human body, it reaches into the cells and produces more protein. This protein resembles the top surface of the virus which puts pressure on the immune system to catch the virus without harming humans.
The trial was to be held in April
According to Anthony Fossey, Director of the National Institute of Allergy and Infectious Disease, the initial trial is successful. Also, It will take a year and a half to make it available to patients around the world. Earlier, the trial of this vaccine was to be held in April. But the worldwide figures of patients suffering from coronavirus came out and the date had to be changed.
So far, coronavirus has killed 6,515 people worldwide. Also, 68 in the US. 1,69,524 people around the world are still vulnerable to Corona.
